Accumulated evidence indicates that infection by fungi capable of causing systemic disease usually results in a relatively strong acquired resistance. The working hypothesis for this study was that an antifungal substance, even one with only slight fungistatic activity, could be an effective chemotherapeutic agent by arresting progression of the infection until acquired resistance became effective. The present study involved establishing and evaluating an experimental animal model (coccidioidomycosis in mice) which could be used to test this hypothesis. This model was reasonably similar to the natural disease. Results with infected nontreated animals indicated that the plot of mortality frequency against survival time did not follow a normal distribution curve. Thus, nonparametric procedures were used for evaluation. Use of this model with an established antibiotic (amphotericin B), with a crude preparation of a new antibiotic , and with synthetic organoselenium compounds demonstrated that even low levels of antifungal activity could be detected. The model should be useful not only to test the original hypothesis but also to screen antifungal substances for their potential as chemotherapeutic agents.
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Accumulated evidence indicates that infection by fungi capable of causing systemic disease usually results in a relatively strong acquired resistance. The working hypothesis for this study was that an antifungal substance, even one with only slight fungistatic activity, could be an effective chemotherapeutic agent by arresting progression of the infection until acquired resistance became effective. The present study involved establishing and evaluating an experimental animal model (coccidioidomycosis in mice) which could be used to test this hypothesis. This model was reasonably similar to the natural disease. Results with infected nontreated animals indicated that the plot of mortality frequency against survival time did not follow a normal distribution curve. Thus, nonparametric procedures were used for evaluation. Use of this model with an established antibiotic (amphotericin B), with a crude preparation of a new antibiotic (CB-310), and with synthetic organoselenium compounds demonstrated that even low levels of antifungal activity could be detected. The model should be useful not only to test the original hypothesis but also to screen antifungal substances for their potential as chemotherapeutic agents.
The search for antifungal antibiotics has been attended with few successes. This is particularly true in the case of systemic mycoses, for which only amphotericin B has proven to be clinically useful. Even amphotericin B has limitations because of toxicity and fungistatic rather than fungicidal activity. Although fungicidal activity would be a desirable property, it may not be a necessary requirement. There is convincing evidence that convalescence from naturally acquired systemic mycoses is associated with immunity to reinfection (4) , and, therefore, a fungistatic compound could be an effective chemotherapeutic agent if it slowed or arrested the progression of the disease until protective immunity developed. A All animals were obtained from our colony of inbred dba mice. Only males of the same age (3 months) were used in each experiment. Mice were weighed just prior to infection, again at the initiation of treatment, and weekly thereafter. The averaged initial weight for all animals was 25.1 g with a range of 22.6 to 29.8 g and a standard deviation of :1=1.9 g.
Randomly selected animals were infected by intraperitoneal injection with 0.5 ml of the standardized arthrospore suspension, and were then distributed, again at random, into the several groups used in each experiment. The number of mice per group in the several studies varied between 5 and 10, depending on the total number of animals available. Food and water were available ad libitum at all times.
The antifungal agents used in these studies were the antibiotics amphotericin B and CB-310, and several synthetic organoselenium compounds which had exhibited antifungal activity in experiments in vitro (to be published). (CB-310 is a new antibiotic supplied by A. Prieto, Calbiochem, San Diego, Calif. The organoselenium compounds were supplied by K. Schwarz, Veterans Administration Hospital, Long Beach, Calif.) The antifungal agents were dissolved in dimethyl sulfoxide (DMSO) in sufficient concentration so that the subsequent dilutions used for treating the mice contained a final concentration of 10% DMSO. Groups of infected animals as controls were treated with saline and with 10% DMSO on the same schedule as those receiving chemotherapy. Since there was no difference between these two control groups, the results for both have been pooled. Treatments were begun on the 5th day postinfection, since earlier studies had shown that the infection was established extraperitoneally by this time. Therapy was administered by daily intraperitoneal injection of 0.5 ml of drug dissolved in 10% DMSO for 5 days. Deaths were recorded in the morning every day of the week for 30 days, and survivors on day 30 were sacrificed. Since C. immitis arthrospores convert to characteristic endosporulating spherules in vivo, this was used as the criterion for determining that infection had been established. Animal tissues, particularly lung, liver, and spleen, were examined microscopically.
RESULTS
The principal question posed in these studies was whether the established experimental animal model of coccidioidomycosis would be appropriate for detecting and evaluating in vivo antifungal activity. The essential problem was to measure not only survival, but also a significant increase in survival time for treated animals compared to controls. Statistical methods are available for analyzing this type of problem. The first objective was to determine which of these methods was appropriate for evaluating the type of results generated by the experimental model. If the frequency of mortality among infected animals without treatment followed a normal distribution curve, then parametric statistics based on normality could be used; if not, then nonparametric statistical tests for significance were to be used. Plots of mortality frequency against time in models of chronic infectious disease usually reveal a skewed distribution (e.g., 12); therefore, the assumption that this characteristic is distributed normally within a given population of animals may or may not be justified, depending upon the extent to which the skewed distribution deviates from the normal. The first objective, therefore, was to determine whether survival times among infected nontreated mice in this experimental model were distributed normally.
The complete results for control animals from seven separate experiments are presented in Table  1 , with the plot of the frequency distribution in Fig. 1 (weight loss, lethargy, ruffled fur) was apparent in all mice by the end of the first postinfection week, but the two survivors appeared well and were gaining weight at the time of sacrifice on day 30 . Endosporulating spherules were demonstrated in lesions within every animal, including the survivors. The curve illustrating the mortality frequency ( Fig. 1) comparison with treated animals before effective acquired resistance became a significant factor. Appropriate procedures for statistical evaluation were tested for validity. There are, however, certain qualifications with respect to this particular animal model of coccidioidomycosis. Natural infection in this disease occurs after inhalation of spores, and experimental infection via the respiratory route would have been more appropriate. This procedure, however, would have been hazardous for laboratory personnel, as the proper equipment was not available at the time the experiments were performed. Infection via the intraperitoneal route, followed by a delay of 5 days before treatment was started, was a compromise, but it did allow for initiation of extraperitoneal infection before organisms in the peritoneal cavity were exposed directly to antifungal compounds.
The statistical approach employed in these experiments requires comment. Parametric statistics are relatively more efficient than nonparametric methods. The former, however, usually require that the characteristic being measured should be distributed normally in the population studied so that the calculated parameters defining the normal frequency distribution (mean and standard deviation) can be used with confidence in their validity. In animal models of infectious diseases, the frequency distribution curves for survival times commonly deviate from the normal distribution curve, either by asymmetry (skewness) or by kurtosis (symmetrical curve but with too many or too few observations concentrated about the center of the range). If one wishes to use the more efficient parametric statistical methods, then one is obliged to determine whether such a deviation exists and, if so, whether the deviation from normal is great enough to invalidate analyses by usual normal statistics. The alternative would be to use the nonparametric methods which make no assumptions regarding distribution. Gehan's (2) (Tables  3 and 4 ). Prolonging the period of therapy up to the beginning of an efficient acquired resistance should result in increased numbers of survivors, as predicted by the original hypothesis. This is the subject of continuing investigation.
